Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel method for preparing thienopyrimidine compound and intermediate

A technology for compounds and mixtures, applied in the field of novel intermediates, can solve problems such as difficulty in purifying compounds, and achieve the effects of easy mass production and effective mass production

Inactive Publication Date: 2019-08-27
HANMI PHARMA
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, it is difficult to purify the compound of formula D and the compound of formula 1 by unsuitable column chromatography which is difficult to apply to industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel method for preparing thienopyrimidine compound and intermediate
  • Novel method for preparing thienopyrimidine compound and intermediate
  • Novel method for preparing thienopyrimidine compound and intermediate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0059] The preparation method according to the present disclosure includes step 1): obtaining the compound of formula 3 through the reaction between the compound of formula 4 and the compound of formula 5 in the presence of a base in an organic solvent.

[0060] In one embodiment, the compound of formula 3 may be (3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidine -4-yl)oxy)phenyl) tert-butyl carbamate or (3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3, 2-d]Pyrimidin-4-yl)oxy)phenyl)carbamate benzyl ester.

[0061] In one embodiment regarding step 1), in the presence of a base in an organic solvent, the compound 4-chloro-N-(4-(4-methylpiperazin-1-yl)phenyl)thieno [3,2-d]pyrimidin-2-amine is reacted with tert-butyl (3-hydroxyphenyl)carbamate, an example of a compound of formula 5 . Then, water or a mixed solvent of an organic solvent and water is added thereto for crystallization, and the product obtained is filtered to obtain (3-((2-((4-(4-methyl...

preparation Embodiment 1

[0165] Preparation Example 1. Preparation of (3-hydroxyphenyl) tert-butyl carbamate

[0166] 10 g (0.0916 mol) of 3-aminopentanol was dissolved in 500 ml of tetrahydrofuran, and 27 ml (0.119 mol) of di-tert-butyl dicarbonate was added thereto. The mixed solution was then stirred at a temperature of 25°C (room temperature) for 1 hour. After the reaction was completed, a mixed solvent of 25 ml of isopropanol and 50 ml of hexane was added to the residue to remove the solvent by distillation under reduced pressure, and the resulting solution was stirred for 2 hours. The resulting solid was filtered, washed with 50 ml of hexane, and dried at 40°C, whereby 17 g (yield: 90%) of tert-butyl (3-hydroxyphenyl)carbamate was obtained as the title compound as a white solid.

[0167] 1 H-NMR (300MHz, DMSO-d 6)δ9.25(s,1H),9.18(s,1H),7.01(m,1H),6.97(d,1H),6.83(dd,1H),6.34(m,1H),1.45(s,9H )

preparation Embodiment 2

[0168] Preparation Example 2. Preparation of 4-chloro-N-(4-(4-methylpiperazin-1-yl)phenyl)thieno[3,2-d]pyrimidin-2-amine

[0169] Dissolve 150g (0.44mol) of 2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4(3H)-one in 600ml of acetonitrile While raising the reaction temperature to 75°C, 124ml of phosphorus oxychloride (POCl 3 ) diluted in 150ml of acetonitrile solution. The mixed solution was then stirred at a temperature of 75° C. for 1 hour. After the reaction was completed, the reaction temperature was cooled to 25°C, and 1.5 liters of cooling water at a temperature of 0°C to 4°C was slowly added to the reaction solution. Then, an aqueous solution prepared by dissolving 263 g of sodium hydroxide in 750 ml of water was added to the reaction solution while maintaining the reaction temperature at 20° C. or lower, and the resulting reaction solution was stirred at a temperature of 25° C. for 1 hour . The resulting solid was filtered, washed with 1.5 liters...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a novel method for preparing a thienopyrimidine compound having activities of selectively inhibiting tyrosine kinase, particularly mutant epidermal growth factor receptor tyrosine kinase, and a novel intermediate used therefor. The present invention can industrially mass-produce, more simply and efficiently than the prior art, a compound of formula (1), which is useful as a therapeutic agent for non-small cell lung cancer induced by mutant epidermal growth factor receptor tyrosine kinase.

Description

technical field [0001] The present invention relates to a novel process for the preparation of thienopyrimidine compounds having selective inhibitory activity against tyrosine kinases, particularly mutant epidermal growth factor receptor tyrosine kinases, and novel intermediates useful in the novel process. Background technique [0002] US 8,957,065 and WO 2011 / 162515 each disclose a thienopyrimidine compound of formula 1 that selectively inhibits the activity of mutant epidermal growth factor receptor tyrosine kinase. [0003] [Formula 1] [0004] [0005] In addition, these documents each disclose a method for preparing the compound of Formula 1. Specifically, as shown in Reaction Scheme 1, 2,4-dichlorothieno[3,2-d]pyrimidine of formula A reacts with 3-nitrophenol to generate a compound of formula B, which reacts with 4-( 4-methylpiperazin-1-yl) aniline is reacted to prepare the compound of formula C, the nitro group of the compound of formula C is reduced to obtain t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D495/04A61K31/519A61K31/496
CPCC07D495/04A61K31/519A61K31/496
Inventor 金熙哲河泰曦徐贵贤
Owner HANMI PHARMA